Phase Ii Trial Of R-Chop Plus Maintenance Rituximab For Previously Untreated Intermediate Or High Grade Non-Hodgkin'S Lymphoma (Ihgnhl) With Filgrastim Support For Older Patients Greater Than 60 Years.
JOURNAL OF CLINICAL ONCOLOGY（2005）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要